Trastuzumab with either docetaxel or vinorelbine as first-line treatment for patients with HER2-positive advanced breast cancer: a retrospective comparison
<p>Abstract</p> <p>Background</p> <p>Combinations of trastuzumab with either docetaxel or vinorelbine are considered valuable treatment options for HER2-positive metastatic breast cancer patients. We performed a retrospective comparison of the clinical outcomes associated with either one of these co...
Збережено в:
| Автори: | , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2010-02-01
|
| Серія: | BMC Cancer |
| Онлайн доступ: | http://www.biomedcentral.com/1471-2407/10/28 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|